Results of the LEVEL Study

Show Description +

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Results of the LEVEL Study

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Please log in to leave a comment.

More in Retina

Sub-ILM Hemorrhage in the Macula

Frédéric Aissani, MD

Restoring Vision With a Subretinal Neurostimulation System

Mahi Muqit, MBChB, BSc (Hons), FRCOphth, PhD

Gene Therapy Programs to Watch in AMD

Arshad M. Khanani, MD, MA, FASRS